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E-mail address: pante@zoology.ubc.ca (N. Panté).Nucleoporin 153 (Nup153), a component of the nuclear pore complex (NPC), has been implicated in
the interaction of the NPC with the nuclear lamina. Here we show that depletion of Nup153 by RNAi
results in alteration of the organization of the nuclear lamina and the nuclear lamin-binding pro-
tein Sun1. More striking, Nup153 depletion induces a dramatic cytoskeletal rearrangement that
impairs cell migration in human breast carcinoma cells. Our results point to a very prominent role
of Nup153 in connection to cell motility that could be exploited in order to develop novel anti-can-
cer therapy.
Structured summary:
MINT-7893777: Lamin-A/C (uniprotkb:P02545) and NUP153 (uniprotkb:P49790) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
MINT-7893761: sun1 (uniprotkb:Q9D666) and Lamin-A/C (uniprotkb:P02545) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The mammalian nuclear pore complex (NPC) is composed of
multiple copies of 30 different nucleoporins [1]. The nucleoporin
153 (Nup153) is strategically positioned at the NPC nuclear bas-
ket to interact with the nuclear lamina, and at least in vitro, it
interacts with lamin B3 [2]. Recent ﬁndings demonstrate that
the nuclear lamina is connected with cytoskeletal elements
through the linker of nucleoskeleton and cytoskeleton (LINC)
complex that spans the double membrane of the nuclear enve-
lope (NE) [3,4]. This complex is formed by outer nuclear mem-
brane Nesprins (actin-binding proteins) and inner nuclear
membrane Sun proteins (lamin-binding proteins), which are
tethered together at the perinuclear space. To determine
whether Nup153 plays a role in the organization of the NE
and thereby indirectly impacts the cytoskeletal architecture
and mechanical properties of the cell, we employed an siRNA ap-chemical Societies. Published by E
on sequence; EdU, ethynyl
toskeleton; MTOC, microtu-
clear pore complex; Nup153,proach to reduce the cellular expression of Nup153. Our data
suggest that Nup153 plays an essential role in maintaining
nucleoskeleton and cytoskeleton architecture, and is required
for cell cycle progression and cell migration.
2. Materials and methods
2.1. Cells, antibodies and Nup153 RNAi
Cells were cultured at 37 C and 5% CO2 in complete Dulbecco’s
modiﬁed Eagle medium supplemented with 10% FBS, penicillin–
streptomycin, and 2 mM L-glutamine. Cells used were: HeLa cells
(American Type Culture Collection), tetracycline-inducible HeLa
cells stably expressing Sun1 carrying a C-terminal GFP tag
(Sun1-GFP [5]; courtesy of Dr. B. Burke and Dr. K. Roux, University
of Florida), human breast carcinoma MDA231 cells and human
ﬁbrosarcoma HT1080 cells (courtesy of Dr. C. Roskelley, University
of British Columbia).
The following antibodies were used: monoclonal SA1 against
human Nup153 [6] (provided by Dr. B. Burke, Institute of Molecular
and Cell Biology, Singapore), polyclonal anti-lamin A/C antibody
(sc-20681; Santa Cruz Biotechnology), monoclonal anti-actin
(AC-40; Sigma), monoclonal anti-a-tubulin (Sigma), polyclonal
anti-c-tubulin (Sigma), monoclonal anti-ﬁbrillarin (38F; Abcam),lsevier B.V. All rights reserved.
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Phalloidin-FITC was obtained from Sigma. For indirect immunoﬂu-
orescence analysis, secondary antibodies were from Invitrogen. For
Western blot, the isotype-speciﬁc HRP-coupled secondary antibod-
ies were from Amersham Pharmacia.
For RNAi, cells were either mock transfected or transfected with
siRNA (Dharmacon) against Nup153 at a ﬁnal concentration of
10 nM using lipofectamine RNAiMAX (Invitrogen) according to
the manufacture’s instructions. The sequence used corresponded
to nucleotide 2593–2615 of human Nup153 (AAGGCAGACUCU-
ACCAAAUGUTT). Expression of Nup153 was assessed by Western
blot and immunoﬂuorescence microscopy one, two and three days
after transfection.Fig. 1. Nup153 depletion by RNAi alters the cell cycle. (A) Western blot of extracts from m
after transfection, and probed with the SA1 antibody to detect Nup153, as well as an a
proﬁles of HeLa cells untransfected, mock transfected and Nup153-siRNA transfected,
ﬂuorescent intensity of the staining for the incorporated EdU (y axis) and the ﬂuorescent D
G2/M and S phases of the cell cycle are indicated in the upper left corner of the plots. (C) P
of untransfected cells. Shown are the mean values and standard error measured for three
treated HeLa cells reveals a loss of NE-associated Nup153, 48 h post-transfection. Cells w
DAPI.2.2. Immunoblotting and immunoﬂuorescence microscopy
Whole cells extracts were prepared by cell lysis in RIPA buffer
(150 mM NaCl, 50 mM Tris–HCl pH 8.0, 0.5 mM EDTA, 0.5% sodium
deoxycholate, 0.1% SDS, 0.5% NP-40, 10 mM PMSF, 1 lm pepstatin,
10 lg/ml aprotinin, and 2 mg/ml leupeptin). The lysates were incu-
bated for 20 min on ice. After centrifugation at 15 000g for
10 min at 4 C, the supernatants were mixed with SDS–PAGE sam-
ple buffer. Protein concentration was determined using the BCA™
protein assay kit (Pierce, Rockford, IL), and aliquots with equal
amounts of proteins were loaded on SDS–PAGE. Proteins were
transferred to nitrocellulose membranes (Bio-Rad), and speciﬁc
proteins were detected with indicated primary antibodies andock-transfected and Nup153-siRNA-transfected HeLa cells prepared 1, 2 and 3 days
nti-ﬁbrillarin antibody as an internal standard. (B) Representative ﬂow cytometric
as measured after a 30 min incorporation of EdU. The dot histograms show the
NA probe 7-amino-actinomycin D (7-AAD; x axis). The percentage of cells in the G1,
ercentage of cells in each cell cycle phase, presented as a percentage of the G1 phase
independent experiments. (D) Immunoﬂuorescence microscopy of Nup153-siRNA-
ere probed with an anti-Nup153 antibody, and DNA was detected by staining with
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cia) using a chemiluminescence kit (GE Healthcare, UK).
For immunoﬂuorescence microscopy, cells were grown on glass
coverslips. After RNAi transfection as indicated above, cells were
ﬁxed with paraformaldehyde, permeabilized with Triton X-100,
and incubated with antibodies by standard immuno-ﬂuorescence
protocols [5]. Samples were analyzed with an Olympus Fluvial
FV1000 confocal microscope.
2.3. Flow cytometry analysis
Cell cycle analysis was performed two days post-transfection
after labeling the cells with 5-ethynyl-20-deoxyuridine (EdU) for
30 min at a ﬁnal concentration of 10 lM, using the Click-iT EdU
Alexa Fluor 448 Flow Cytometry Kit (Invitrogen) according to the
manufacture’s instructions. Fluorescence-activated cell sorting
data were collected on a FACS Calibur (Becton Dickinson Immuno-Fig. 2. Nup153 depletion by RNAi alters the localization of the nuclear lamina and Sun1.
or transfected with Nup153-siRNA and labeled with antibodies against Nup153 and la
transfected Sun1-GFP HeLa cells prepared 48 h post-transfection, and probed with antibo
siRNA-treated Sun1-GFP labeled with an antibody against lamin A/C.cytometry Systems, San Jose, CA) and analyzed using FlowJo
software.2.4. Cell migration assay
Cells were grown on 35 mm glass bottom dishes. After RNAi
transfection as indicated above, cells were grown to conﬂuence.
Two days post-transfection, conﬂuent monolayers were wounded
by scratching with P20 pipette tips. Samples were washed with
PBS to remove ﬂoating cells, and FBS-free media was added. To as-
sess the extent of wound closure, phase contrast images were ob-
tained with a ZEISS inverted microscope. Quantiﬁcation of the
wound that remained uncovered by the migrating cells at different
times after the introduction of the wound was conducted by trac-
ing the edge of the wound, and calculating the remaining wound
area using ImageJ software.(A) Double indirect immunoﬂuorescence microscopy of HeLa cells mock-transfected
min A/C. (B) Western blot of extracts from mock-transfected and Nup153-siRNA-
dies against Nup153 and ﬁbrillarin. (C) Immunoﬂuorescence microscopy of Nup153-
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wound, ﬁxation and staining were performed six hours after
wounding.Fig. 3. Nup153 depletion by RNAi results in rearrangement of the cytoskeleton. (A)
Phalloidin staining of the actin cytoskeleton of mock-transfected and Nup153-
siRNA-transfected HeLa cells 48 h post-transfection. DNA was detected with DAPI.
(B) Immunoﬂuorescence microscopy of mock- and Nup153-siRNA-transfected HeLa
cells labeled with an antibody against a-tubulin. (C) Western blot of extracts from
mock-transfected and Nup153-siRNA-transfected HeLa cells prepared 48 h after
transfection, and probed with antibodies against Nup153, lamin A/C, actin,
a-tubulin and ﬁbrillarin. Fibrillarin antibody was used as an internal standard to
control for total protein loaded on each lane of the gel.3. Results
3.1. Nup153 depletion leads to changes in the cell cycle and alteration
of the nuclear lamina organization
To investigate the role of Nup153 beyond nuclear transport and
assembly, we suppressed Nup153 expression in HeLa cells by RNAi
using the siRNA sequence corresponding to nucleotide 2593–2615
of human Nup153. This has been previously shown to accom-
plished efﬁcient depletion of Nup153 in HeLa cells [7]. For control,
cells were mock transfected without siRNA. Nup153-expression le-
vel was monitored over several days, using both Western blotting
of HeLa-cell extracts, and immunoﬂuorescence staining of Nup153.
As illustrated in Fig. 1A, the expression of Nup153 was already re-
duced one day post-transfection. The reduction of Nup153 was
most obvious two or three days post-transfection. At the micro-
scopic level, however, cell proliferation was signiﬁcantly reduced
at three days post-transfection, compared to two days post-trans-
fection. Therefore, two days post-transfection was chosen for fur-
ther experiments throughout this study.
The decreased proliferation rate in the Nup153-siRNA-treated
cells was not due to apoptosis, because we did not observe TUNEL
staining in the Nup153-depleted cells (data not shown). Instead,
we found the Nup153-depleted cells were arrested in G1, as re-
vealed by cell cycle analyses using ethynyl deoxyuridine (EdU)
staining followed by ﬂow cytometry. Compared to untransfected
and mock-transfected cells, the Nup153-siRNA-treated HeLa cells
exhibited a marked increase in the percentage of cells in G1, and
a concomitant decrease in the percentage of cells in S phase
(Fig. 1 B and C). Thus, in addition to its role in mitosis [8–10],
Nup153 plays a role in cell-cycle-regulation.
Indirect immunoﬂuorescence analysis of the Nup153-siRNA-
transfected HeLa cells with the Nup153-speciﬁc monoclonal anti-
body SA1 [6] also demonstrated reduction of the Nup153 by RNAi,
with 80–90% of the cells showing a signiﬁcant reduction of the nor-
mal nuclear-rim staining of Nup153 (Fig. 1D). In addition to mon-
itoring for RNAi silencing of Nup153, the immunostaining revealed
deformation of the nuclei of Nup153-siRNA-transfected cells,
which is more evident after staining the nuclei with DAPI
(Fig. 1D). Because the nuclear lamina plays an important role in
the establishment and maintenance of a regular nuclear morphol-
ogy, we then performed immunostaining with antibodies against
lamin A/C. As illustrated in Fig. 2A, we found that Nup153 deple-
tion resulted in alteration of the nuclear lamina organization.
These alterations include multiple lobes or membrane invagin-
ations spanning the nuclei, as well as a dotted pattern for the
immunolabeling of the lamin A/C (Fig. 2A). Thus, Nup153 (proba-
bly by its interaction with the nuclear lamina) seems to play a role
in the plasticity of the NE.
3.2. Nup153 depletion alters the localization of Sun1 and causes
rearrangement of the cytoskeleton
Since Sun1 is a lamin A-binding protein [3], we investigated
whether the depletion of Nup153 has any effect on the localization
of Sun1. For these experiments, we used HeLa cells expressing
Sun1 carrying a C-terminal GFP tag (Sun1-GFP [5]). Similar to the
RNAi experiments with HeLa cells, Nup153 was signiﬁcantly re-
duced in the Sun1-GFP cells (Fig. 2B). This reduction resulted in
morphologically defected nuclei, and in immunolabeling defects
of Sun1 characterized by a dotted immunolabeling pattern andmembrane invaginations spanning the nuclei (Fig. 2C), similar to
the alterations in the lamin A/C immunostaining of HeLa cells de-
pleted of Nup153.
Because thecytoskeletonplaysan important role in theestablish-
ment andmaintenance of regular nuclear morphology, and because
theNE (through the LINC complex) directly impacts the cytoskeletal
architecture, we hypothesized that depletion of Nup153 induces
cytoskeletal rearrangement. To test this hypothesis, we performed
different immunostainings with antibodies or toxins directed
against cytoskeletal proteins in HeLa cells depleted of Nup153 by
RNAi. As documented in Fig. 3A, RNAi reduction of Nup153 induced
rearrangement of the actin cytoskeleton. Similar experiments, but
immunolabeling themicrotubules instead of the actin cytoskeleton,
also revealed reorganization of the microtubule cytoskeleton in
Nup153-siRNA-transfected cells (Fig. 3B). Western blot analysis,
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expression of actin or a-tubulin in the Nup153-siRNA-transfected
cells compared to mock-transfected cells (Fig. 3C).
3.3. Nup153 depletion affects cell migration and cell polarity in human
breast cancer cells
SinceNup153depletion induces cytoskeleton rearrangement,we
hypothesize that Nup153-siRNA-transfected cells have defects inFig. 4. Nup153 depletion by RNAi in MDA231 cells results in altered cellular morpholo
Nup153-siRNA-treated MDA231 cells reveals a loss of NE-associated Nup153, 48 h post-tr
by staining with DAPI. (B) Western blot of extracts from mock-transfected and Nup153-
antibodies against Nup153, lamin A/C, actin, a-tubulin and ﬁbrillarin. (C) Phase contras
48 h after Nup153-siRNA-treatment. (D) Immunoﬂuorescence microscopy of mock- and
microtubule cytoskeleton 48 h post-transfection. Cells were probed with Phalloidin-FITCcytoskeleton-mediated process, including cell migration, microtu-
bule-organizing centre (MTOC) positionwith respect to the nucleus,
andpolarization. To test this hypothesis,we conductedNup153-siR-
NA-transfection studies in a well-known human breast carcinoma
cell line (MDA-231) that exhibits a very fast migration speed [11].
Because directional cell migration is a fundamental feature in the
metastatic spread of cancer, we reason that if reduction of the levels
of Nup153 in these cells affects theirmigration, Nup153-RNAi could
be developed as a new therapeutic approach against cancer.gy and rearrangement of the cytoskeleton. (A) Immunoﬂuorescence microscopy of
ansfection. Cells were probed with an anti-Nup153 antibody, and DNA was detected
siRNA-transfected MDA231 cells prepared 48 h after transfection, and probed with
t images reveal a dramatic change in the cellular morphology of the MDA231 cells,
Nup153-siRNA–transfected MDA231 cells reveals rearrangement of the actin and
and an anti-a-tubulin antibody. DNA was detected by staining with DAPI.
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pleted by RNAi in MDA231 cells. For this purpose, MDA231 cells
were transfected with and without the same Nup153-speciﬁc siR-
NA we used for HeLa cells. Two days post-transfection, the cells
were analyzed by immunoﬂuorescence microscopy and Western
blot using the SA1 antibody against Nup153. As illustrated in
Fig. 4A and B, through RNAi, the expression of Nup153 was signif-
icantly reduced in MDA231 cells. Similar to HeLa cells, the expres-
sion levels of lamin A/C, actin and a-tubulin did not change in
Nup153-RNAi-transfected MDA231 cells when compared to
mock-transfected MDA231 cells (Fig. 4B). Cellular morphology,
however, was signiﬁcantly altered (Fig. 4C). Similar to HeLa cells,
depletion of Nup153 in MDA231 cells induced dramatic rearrange-
ment of the actin and microtubule cytoskeleton (Fig. 4D).
Having proved that reduction of Nup153 through RNAi in
MDA231 cells induces cytoskeleton rearrangements, we then
investigated the migration response of Nup153-RNAi-treated
MDA231 cells. For this purpose, cells were grown to a conﬂuent
monolayer and subjected to the wound-induced cell migration as-
say as described in Section 2.4. As expected, wound closure oc-
curred signiﬁcantly faster in MDA231 cells (Fig. 5A; see alsoFig. 5. Nup153 depletion affects cell migration and cell polarity in MDA231 cells. (A) Ph
transfected and Nup153-siRNA-transfected MDA231 cells subjected to the wound-ind
Quantiﬁcation of the fraction of the wound that remains uncovered by the migratory cells
cells (n = 3 for each condition). (C) Indirect immunoﬂuorescence microscopy of mo
introduction of the wound. Cells were immunolabeled using antibodies against the Golg
lines indicate the migrating cell front. Arrows point to the MTOC. (D) Quantiﬁcation of th
immunostaining of the Golgi complex and MTOC positioned within a 120 area facing th
error measured for three independent experiments. 100 cells were counted for each co
Nup153-siRNA-transfected MDA231 cells six hours after the introduction of the woundvideos in Supplementary data); however, the rate of wound heal-
ing was signiﬁcantly reduced in the Nup153-RNAi-transfected
MDA231 cells, compared to the mock-transfected MDA231 cells
(Fig. 5A and B). Similar results were obtained after subjecting hu-
man ﬁbrosarcoma cells HT1080 to the wound-induced cell migra-
tion assay 48 h after Nup153-siRNA treatment (Fig. S1).
In addition to measuring the migration rate, we also examined
changes in polarity, determined by the location of the MTOC and
the Golgi complexwith respect to the wound edge, inMDA231 cells
mock transfected or transfected with the siRNA of Nup153. For this
purpose, cell monolayers were immunoﬂuorescence labeled with
c-tubulin and Golgi antibodies six hours after introduction of the
scratch.We found that theMTOC and Golgi complex of mock-trans-
fected MDA231cells were located towards the wound. This is in
contrast to the Nup153-RNAi-transfected MDA231 cells, which
failed to position their MTOC and Golgi complex towards the
wound (Fig. 5C). Quantiﬁcation of the number of cells that had a
polarized MTOC (deﬁned as location of these structures towards
the wound and within a 120 area facing the wound edge) showed
that 82% of themock-transfectedMDA231 cells had theirMTOC ori-
ented towards the wound (Fig. 5D). In contrast, only 42% ofase contrast micrographs show the extent of cell migration in the wound of mock-
uced cell migration assay. The wound was introduced 48 h post-transfection. (B)
as a function of time for mock-transfected and Nup153-siRNA-transfected MDA231
ck-transfected and Nup153-siRNA-transfected MDA231 cells six hours after the
i complex (GM130), and MTOC (c-tubulin). DNA was stained with DAPI. The broken
e cells with polarized Golgi complex (top) and polarized MTOC (bottom). Cells with
e wound edge were assessed as polarized. Shown are the mean values and standard
ndition. (E) Phalloidin staining of the actin cytoskeleton of mock-transfected and
. DNA was stained with DAPI. The broken lines indicate the migrating cell front.
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Similarly, the number of Nup153-RNAi-transfected MDA231 cells
with a polarized Golgi complex was signiﬁcantly lower than the
mock-transfected MDA231 cells (Fig. 5D). In addition, immuno-
staining of the actin ﬁlaments of these cells showed that Nup153-
RNAi-transfectedMDA231 cells had defects in forming lamellipodia
at their leading edge that moves towards the wound (Fig. 5E).
4. Discussion
Nucleoporins, once though to be exclusively structural blocks of
the NPC with roles only in nuclear transport, are emerging as reg-
ulators of diverse cellular functions. This is the case for Nup153,
which in addition to have a structural role in the formation of NPCs
[12,13] and a functional role in nuclear import and export [14–17],
is involved in facilitating the process of NE disassembly during
mitosis [8–10]. The latter function has recently been shown to be
mediated through the association of Nup153 with the spindle
assembly checkpoint protein Mad1 [18]. Our ﬁndings suggest addi-
tional roles for Nup153 in cell cycle progression, nuclear lamina
organization, cell morphology and cell migration.
Given the role of Nup153 in nuclear transport [14–17], one
could argue that the phenotypes observed in this study might be
a consequence of nuclear import defects in cells depleted of
Nup153. A recent study, however, demonstrated that HeLa cells
depleted of Nup153 by RNAi can still carry out efﬁcient global
nucleocytoplasmic transport, which included nuclear import of
the glucocorticoid receptor, nuclear export of a Rev-chimera pro-
tein and nuclear export of poly (A)+ RNA [10]. Consistent with this
study, our nuclear import assays in digitonin-permeabilized cells
show that Nup153-depleted cells are able to nuclear import pro-
teins with classical nuclear localization sequences (cNLSs). Com-
pared to the nuclear import in the mock-transfected cells,
however, the cells transfected with Nup153-siRNA exhibited a
37% reduction in the nuclear concentration of the cNLS-protein
(Fig. S2). Similar nuclear import deﬁciency (about 25% reduction)
has been reported for the nuclear import of GFP fused to a cNLS
in Drosophila cells depleted of Nup153 by RNAi [19]. The slight dif-
ferences of nuclear transport efﬁciency between our study and
those reported previously, may be due to the extend of Nup153
depletion or the assay used to measured nuclear import. Neverthe-
less, we can conclude that the defects we found for the Nup153-de-
pleted cells in cell cycle progression, nuclear lamina organization,
cell morphology and cell migration might not be a direct conse-
quence of impaired nuclear transport.
The defects in cell cycle progression could be explained by a di-
rect role of Nup153 in regulating cell-cycle gene expression, as it
has been recently demonstrated for other nucleoporins [20,21]. Be-
cause Nup153 is mobile and found at the NPC and inside the nucle-
oplasm [22], this gene expression control could be achieved by
Nup153-chromatin interaction at the NPC or within the nucleo-
plasm. Alternatively, the defects in cell cycle progression we de-
tected in the Nup153-RNAi treated cells (Fig. 1B) may be a
consequence of the alteration of the nuclear lamina of these cells,
as nuclear lamina organization plays an important role in the reg-
ulation of DNA synthesis, chromatin organization, and gene tran-
scription (reviewed by [23,24]). For example, siRNA knock down
of lamin A/C leads to cell cycle G1 arrest [25].
In addition to the cell cycle progression defect, we have found
that depletion of Nup153 resulted in alteration of the immunola-
beling of the nuclear lamina and the A-type lamin-binding protein
Sun1. These alterations are not surprising due to the location of
Nup153 at the nuclear periphery of the NPC. Because the nuclear
lamina is connected to cytoskeletal elements through the LINC
complex [3,4], it is expected that conditions that affect the nuclear
lamina will inﬂuence cytoskeletal arrangements and cytoskeleton-mediated process. Thus, depletion of Nup153 by RNAi resulted in
alteration of the nuclear lamina, and consequently in a rearrange-
ment of the cytoskeleton and defects in cytoskeleton-based pro-
cesses. Further work is necessary to address how the cytoskeletal
dynamic is affected when NE components, including the Nup153,
are manipulated. This will have highly relevance in understanding
the molecular basis underlying certain human diseases (e.g. lipo-
dystrophy, muscular dystrophy, neuropathy, and progeria) that
are linked to defects in NE proteins [26,27].
As expected, alterations of the cytoskeleton resulted in defects
in several processes that are governed by the cytoskeletal network.
Because cell migration is a fundamental feature in the metastatic
spread of cancer, we then studied the effect of depleting Nup153
in a human breast carcinoma cell line. We found that depletion
of Nup153 signiﬁcantly reduced the speed of directional cell
migration in the human breast carcinoma MDA231 cell line. These
cells also had polarization defects. Similar migration and polariza-
tion defects have been found in cells lacking lamin A/C [28] and in
Nesprin-2-deﬁcient ﬁbroblasts [29]. Our results with MDA231 cells
suggests that manipulation of the NPC could be used to regulate
cell growth and progression of cancer invasion, and opens the
exciting possibility that RNAi of Nup153 could be developed as
an anti-cancer therapy.
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